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1. Introduction
With the worldwide increasing use of noninvasive ventilation (NIV) and many updated evi-
dences coming under the application of NIV in neuromuscular disease, neonates, and open 
circuit mouthpiece ventilation apart from the documented success of NIV in OSA, COPD, 
type 2 respiratory failure and pulmonary edema, it is the time to get more knowledge about 
its application for various chronic respiratory diseases such as interstitial lung disease and 
non-respiratory disease characterized by type 1 or type 2 respiratory failure in due course of 
time, and it is also important to know the potential application of NIV in children and neo-
nates and as a mode for weaning from the mechanical ventilation, NIV is a rapidly changing 
field; hence, it is very important in clinical practice to have expertise in applying the technique 
and acquiring problem-solving skills of NIV.
If we go back to history, initially, negative pressure ventilators were invented primarily to tide 
over the ventilatory crisis of polio epidemic (epidemics of poliomyelitis), which had begun in the 
First World War and swept across Europe and the USA in the 1930s–1950s. They were of differ-
ent types including cuirass ventilator, chest bellow, iron lung, tank ventilators, and many more 
but the main drawback with all these was that they were large, heavy, and cumbersome to oper-
ate and handle and were primarily used for the neuromuscular disease. Practical limitations 
were compounded by the huge outbreak of polio in Denmark in 1952, which was associated 
with a very high prevalence of cases with bulbar weakness. Not only an insufficient number of 
iron lungs were available, but these were also inadequate in caring for patients with bulbar prob-
lems—mortality rose to 90% and the only solution was invasive positive-pressure ventilation via 
a tracheostomy. This switch to positive pressure continued heralding the development of mod-
ern ICU. Later on, positive-pressure ventilators were developed with endotracheal intubation, 
which is a must for the application of these ventilators. From 1980 onward, positive pressure 
was applied through the face mask and found to be really effective for patients with COPD and 
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obstructive sleep apnea, and it heralded the era of NIV globally. There was a brief resurgence of 
NIV in 1980s, but mainly to care for those with chronic ventilatory failure.
Long-term chronic use of NIV began to spur to ventilatory progress during 1980s. This was 
related to better understanding of the sleep physiology and the discovery of OSA and ben-
eficial effects of CPAP. The original CPAP machines were very large, but newer machines are 
smaller, compact, and portable. Importantly, mask design and comfort has also improved, 
leading to success of NIV application. NIV is now one of the most evidence-based areas of 
respiratory medicine. NIV reduces mortality and morbidity in acute exacerbations of COPD, 
and this improved outcome in Duchenne muscle dystrophy and other neuromuscular dis-
eases, OSA, in acute hypoxemic respiratory failure secondary to pulmonary edema and wean-
ing from mechanical ventilation including high-risk patients for weaning. An additional major 
change in the past 30–40 years has been the increasing indications for long-term, chronic NIV 
and, of course, long-term application of CPAP in OSA.
For patients with a range of causes of ventilatory failure, the natural history progresses from 
normal breathing to a gradual loss in lung volumes and then, initially, changes in blood gases 
are seen at night due to hypoventilation, and if that is not addressed, ultimately, progress to day-
time respiratory failure, cardiac decompensation, and premature death. In Duchenne muscular 
dystrophy and other neuromuscular diseases, once a patient starts  developing high carbon 
dioxide level during the daytime and or night time, suggestive of ventilatory muscles fatigue 
and carries a dismal prognosis if the Home NIV support is not provided earliest possible. In 
COPD, recent trials have shown NIV may be beneficial in stable hypercapnic patients. NIV has 
been extended to the pediatric age range, with the feasibility of using NIV to control noctur-
nal hypoventilation in children initially being demonstrated predominantly in neuromuscular 
conditions. Many of these children now survive to adolescence or adulthood, as shown in the 
section entitled “Chronic NIV in hereditary neuromuscular disorders.”
There is also growing interest in NIV in cardiology. There is no doubt that patients with heart 
disease and OSA benefit from treatment of the OSA. By contrast, Cheyne-Stokes respiration 
is a form of central sleep apnea in patients with chronic heart failure. Recent work shows that 
around half of patients with mild heart failure have sleep disordered breathing too. CPAP 
can be used to treat OSA, but it does not work in central sleep apnea or Cheyne-Stokes res-
piration. NIV is now being used in some situations to palliate symptoms without the aim of 
prolonging survival. Here, goals such as reduction in dyspnea and control of symptoms of 
nocturnal hypoventilation should be set preemptively so that if these are not met, NIV can be 
discontinued and palliative efforts are directed elsewhere. NIV combined with cough assist 
devices can also be used to manage severely ill type 1 spinal muscular atrophy infants with 
the aim of discharging the patient to their home and managing breathlessness.
2. Implementation of NIV in clinical practice
There is evidence that patients who would benefit from NIV are not receiving it even for gold 
standard indications, such as acute hypercapnic COPD, mainly because the medical team does 
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not feel comfortable to start NIV; in such case, they must take MICU or pulmonary medicine 
doctor’s opinion for the NIV in COPD and they must try to emphasize the use of NIV to the 
patients to improve quality of life and to reduce morbidity and mortality in not only COPD but 
also in all well-established indications for NIV use in various respiratory diseases. Pulmonary 
and MICU doctors are at forefront to recommend the use of NIV in established and potential 
indications to improve quality of life and survival.
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